NCT02262533 Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02262520 Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02260947 Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints Status COMPLETED Phase PHASE1
NCT02260466 Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement. Status ACTIVE_NOT_RECRUITING Phase NA
NCT02255565 Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study Status COMPLETED Phase PHASE4
NCT02255227 Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD Status TERMINATED Phase PHASE2
NCT02251054 Virtual Avatar Coaches for Behavioral Therapy of Patients With Overactive Bladder Status COMPLETED Phase NA
NCT02247583 Investigating Patient Satisfaction With Oral Anti-Cancer Treatment Status COMPLETED Phase N/A
NCT02243852 Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21) Status WITHDRAWN Phase N/A
NCT02240459 A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment Status COMPLETED Phase PHASE2
NCT02239380 Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan Status COMPLETED Phase PHASE3
NCT02238717 Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints Status COMPLETED Phase PHASE1
NCT02238496 Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas Status COMPLETED Phase PHASE1
NCT02237742 A Study To Understand How The Body Reacts To A Low Dose Of PF-06427878 When Given In A Vein To Healthy, Adult, Males Status COMPLETED Phase PHASE1
NCT02237729 A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07)) Status COMPLETED Phase PHASE1
NCT02231957 Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions Status COMPLETED Phase NA
NCT02228382 Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors Status TERMINATED Phase PHASE4
NCT02227550 Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy Status COMPLETED Phase PHASE4
NCT02226172 Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib Status TERMINATED Phase PHASE2
NCT02226003 Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017) Status COMPLETED Phase PHASE3